首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.
【2h】

Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.

机译:抗M2阳性和抗M2阴性原发性胆汁性肝硬化患者的新型线粒体抗原抗体系统(M9 / anti-M9)的特征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new antimitochondrial antibody (AMA) against an outer membrane associated antigen on liver mitochondria was detected by ELISA in sera from patients with primary biliary cirrhosis (PBC). This antibody was named anti-M9. There is evidence that it is a partial organ-specific antibody as shown by absorption studies using submitochondrial particles prepared from heart, liver and kidney. A purified M9-fraction was prepared by subjecting a 100,000 g supernatant from rat liver mitochondria to ion exchange chromatography. This fraction was devoid of the previously described M1-M8 antigens except for M4. Trypsin treatment of the fraction enabled a distinction to be made between M4 which was protease resistant, and M9 which was trypsin sensitive. Applying this M9-fraction in Western blotting anti-M9 positive sera recognized two proteins at a molecular weight of 98 kD and 59 kD. Anti-M9 antibodies were detected in 37% of 156 anti-M2 positive as well as in 82% of 22 anti-M2 negative patients with histologically proven PBC. It is concluded that anti-M9 is a new AMA type in PBC which may be helpful especially for the early diagnosis of PBC in patients who are still anti-M2 negative. As one of the earliest immunological signs in PBC further characterization of M9 could provide new insights into the etiopathogenesis of the disease.
机译:ELISA法检测了原发性胆汁性肝硬化(PBC)患者血清中针对肝线粒体外膜相关抗原的新抗线粒体抗体(AMA)。该抗体被称为抗M9。有证据表明,它是一种局部器官特异性抗体,如使用从心脏,肝脏和肾脏制备的线粒体颗粒的吸收研究所显示的那样。通过将来自大鼠肝线粒体的100,000 g上清液进行离子交换色谱法来制备纯化的M9级分。除M4外,该级分不含先前描述的M1-M8抗原。用胰蛋白酶处理该级分可以区分蛋白酶抗性的M4和胰蛋白酶敏感的M9。将这种M9馏分用于Western印迹,可检测抗M9阳性血清的两种蛋白质,分子量分别为98 kD和59 kD。经组织学证实为PBC的156例抗M2阳性患者中有37%以及22例抗M2阴性患者中有82%检测到抗M9抗体。结论是,抗M9是PBC中的一种新型AMA类型,可能尤其有助于仍抗M2阴性的患者的PBC早期诊断。作为PBC中最早的免疫学标志之一,M9的进一步表征可以提供对该疾病的病因学的新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号